Details:

The Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC) is a network of clinicians, scientists, and industry partners pooling their efforts on IBD research across Australia and New Zealand. Formed in 2008, it links 21 gastroenterology centres and runs a shared biobank, which lets researchers run multi-centre clinical trials, cohort studies, and genetics and phenotyping work, and improve the quality of care for patients in both countries.